Determinants of Endogenous Fibrinolysis in Whole Blood Under High Shear in Patients With Myocardial Infarction.
JACC Basic Transl Sci
; 7(11): 1069-1082, 2022 Nov.
Article
en En
| MEDLINE
| ID: mdl-36687271
Hypofibrinolysis is a recently-recognized risk factor for recurrent cardiovascular events in patients with ST-segment elevation myocardial infarction (STEMI), but the mechanistic determinants of this are not well understood. In patients with STEMI, we show that the effectiveness of endogenous fibrinolysis in whole blood is determined in part by fibrinogen level, high sensitivity C-reactive protein, and shear-induced platelet reactivity, the latter directly related to the speed of thrombin generation. Our findings strengthen the evidence for the role of cellular components and bidirectional crosstalk between coagulatory and inflammatory pathways as determinants of hypofibrinolysis.
ACS, acute coronary syndrome; LT, lysis time; MACE, major adverse cardiovascular events; OT, occlusion time; PAI, plasminogen activator inhibitor; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction; fibrinolysis; myocardial infarction; platelet function; t-PA, tissue plasminogen activator; thrombosis; vWF, von Willebrand factor
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Risk_factors_studies
Idioma:
En
Revista:
JACC Basic Transl Sci
Año:
2022
Tipo del documento:
Article
País de afiliación:
Reino Unido